These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18437783)

  • 21. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia.
    Shefer A; Markowitz L; Deeks S; Tam T; Irwin K; Garland SM; Schuchat A
    Vaccine; 2008 Aug; 26 Suppl 10():K68-75. PubMed ID: 18847559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of human papillomavirus vaccination in developed countries.
    Brisson M; Van de Velde N; Boily MC
    Public Health Genomics; 2009; 12(5-6):343-51. PubMed ID: 19684446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent girls' attitudes on human papillomavirus vaccination.
    Chan SS; Yan Ng BH; Lo WK; Cheung TH; Hung Chung TK
    J Pediatr Adolesc Gynecol; 2009 Apr; 22(2):85-90. PubMed ID: 19345913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of women's health--HPV vaccination after 16 years of age?
    Mogensen O
    Acta Obstet Gynecol Scand; 2009; 88(7):756-7. PubMed ID: 19452303
    [No Abstract]   [Full Text] [Related]  

  • 26. What about the boys?
    Jayabarathan A
    Can Fam Physician; 2008 Oct; 54(10):1375; author reply 1377. PubMed ID: 18854456
    [No Abstract]   [Full Text] [Related]  

  • 27. Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program.
    Tozzi AE; Ravà L; Stat D; Pandolfi E; Marino MG; Ugazio AG
    Vaccine; 2009 Apr; 27(19):2625-9. PubMed ID: 19428869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

  • 29. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL
    Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The case for vaccinating boys against human papillomavirus.
    Hull SC; Caplan AL
    Public Health Genomics; 2009; 12(5-6):362-7. PubMed ID: 19684448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural differences among cost-effectiveness models of human papillomavirus vaccines.
    Insinga RP; Dasbach EJ; Elbasha EH
    Expert Rev Vaccines; 2008 Sep; 7(7):895-913. PubMed ID: 18767941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy debate over human papillomavirus vaccines.
    Richman S
    J Low Genit Tract Dis; 2009 Apr; 13(2):128. PubMed ID: 19387138
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands.
    Rogoza RM; Westra TA; Ferko N; Tamminga JJ; Drummond MF; Daemen T; Wilschut JC; Postma MJ
    Vaccine; 2009 Jul; 27(35):4776-83. PubMed ID: 19539578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of the readiness for introduction of the HPV vaccine in Uganda.
    Katahoire RA; Jitta J; Kivumbi G; Murokora D; Arube WJ; Siu G; Arinaitwe L; Bingham A; Mugisha E; Tsu V; LaMontagne DS
    Afr J Reprod Health; 2008 Dec; 12(3):159-72. PubMed ID: 19435020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What about the boys?
    Batty HP
    Can Fam Physician; 2008 Oct; 54(10):1375; author reply 1377. PubMed ID: 18854457
    [No Abstract]   [Full Text] [Related]  

  • 36. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
    Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
    Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS.
    Christian WJ; Christian A; Hopenhayn C
    J Adolesc Health; 2009 May; 44(5):437-45. PubMed ID: 19380090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER
    Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
    [No Abstract]   [Full Text] [Related]  

  • 40. Education about human papillomavirus and human papillomavirus vaccines in adolescents.
    Kollar LM; Kahn JA
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):479-83. PubMed ID: 18797272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.